The mechanism of chloramphenicol resistance was examined in a high-level-resistant isolate of Pseudomonas cepacia from a patient with cystic fibrosis. We investigated potential resistance mechanisms, including production of chloramphenicol acetyltransferase, ribosomal resistance, and decreased permeability. This strain (MIC, 200 ,ug/ml) had no detectable chloramphenicol acetyltransferase activity. In in vitro translation experiments in which we compared the resistant isolate with a susceptible strain of P. cepacia, inhibition of amino acid incorporation was equivalent even in organisms that were preincubated with sub-MICs of chloramphenicol. A 21.9-kilobase (kb) fragment of DNA was cloned which coded for chloramphenicol resistance; this fragment was expressed in P. cepacia but not in Escherichia coli. Quantitation of chloramphenicol uptake in the isogenic pair of susceptible and resistant organisms revealed a nearly 10-fold decrease of drug entry into the resistant strain. Comparison of isolated outer membrane proteins and lipopolysaccharide patterns identified no significant differences between the isogenic pair of organisms. We concluded that the mechanism of chloramphenicol resistance in this strain is decreased permeability.
Pseudomonas cepacia is an important nosocomial pathogen and an organism that can cause severe pulmonary infections in children and young adults with cystic fibrosis (CF). Originally recognized as a plant pathogen in 1950 (5), the role of P. cepacia in hospital-acquired infections of the urine, lungs, and bloodstream was first reported in the early 1970s (12, 19, 22, 28, 35) . Colonization with P. cepacia occurs late in the course of pulmonary disease in patients with CF, and in several CF centers, outbreaks of virulent strains have resulted in severe and overwhelming pneumonia in a subpopulation of patients (21, 37) .
The major problem in the treatment of infections caused by P. cepacia is multiple antibiotic resistance. Isolates from patients with CF, in particular, are often highly resistant to the P-lactam agents and aminoglycosides that are used to treat Pseudomonas aeruginosa (4, 9, 15) . Antibiotics with clinical efficacy against P. cepacia include chloramphenicol, trimethoprim, and the quinolones (12, 21, 28) . However, more than half of clinical isolates may be resistant to these agents as well. Investigations of chloramphenicol resistance in P. cepacia strains from patients with CF consistently report that 45 to 50% of isolates are resistant (MIC, .10 ,ug/ml).
In this report we describe the characterization of chloramphenicol resistance in P. cepacia. We used an isolate of P. cepacia from a patient with CF; this isolate was resistant to chloramphenicol, trimethoprim, and ciprofloxacin, as well as all P-lactams and aminoglycosides tested, and was selected to characterize the resistance mechanism. We cloned a 21.9-kilobase (kb) DNA fragment that encoded resistance to chloramphenicol in P. cepacia but that was not expressed in Escherichia coli. Potential mechanisms of resistance, including enzymatic inactivation by chloramphenicol acetyltransferase (CAT), decreased ribosomal susceptibility, and * Corresponding author. impermeability, were examined in both the clinical isolate and a strain expressing the cloned gene.
MATERIALS AND METHODS
Strains and plasmids. The P. cepacia and E. coli strains used in this investigation are listed in Table 1 , as are the plasmid and cosmid vectors used in cloning and the plasmids constructed during these experiments, Media. The liquid medium used in this study was L broth (27) . Broth cultures were incubated at 37°C and shaken at 150 cycles per min. The solid medium used was L agar for E. coli strains and OFPBL (45) (39) with spooling out the DNA on a glass rod. Plasmid DNA was purified from E. coli and P. cepacia by the alkaline lysis technique of Birnboim and Doly (2) followed by ethidium bromide-cesium chloride ultracentrifugation. Small amounts of less pure plasmid were prepared for analysis by a smallscale alkaline lysis technique (27) . DNA was analyzed by 0.7% agarose horizontal slab gel electrophoresis in Tris borate buffer (27) .
Cosmid cloning. P. cepacia K61-3 whole-cell DNA was partially digested with Sall, to produce a majority of fragments in the range of 15 to 30 kb. This DNA was electrophoresed on a preparative 0.5% low-melting-point agarose gel (SeaPlaque), the band between 15 and 30 kb was cut out, and the DNA was extracted (27) . Cosmid pVK102 DNA was digested to completion with SalI and combined with insert DNA (Sall-cut whole-cell DNA from K61-3) in a ratio of 1:2. The DNA was ligated with T4 DNA ligase (27) and packaged with a lambda phage DNA packaging kit (Gigapak) from Vector Cloning Systems (San Diego, Calif.). E. coli HB101 was grown to the mid-log phase in L broth with 0.01 M MgSO4 and 0.4% maltose and was used for transfection (20) . Transfections were plated onto L agar containing 50 ,ug of kanamycin per ml. The resultant colonies were screened for inserts by placing them with a toothpick onto media containing 50 ,ug of tetracycline or 100 ,ug of chloramphenicol per ml.
Triparental mating experiments. Plasmid pRK2013 was used to mobilize pVK102 clones into P. cepacia 249-2. Matings were done overnight on filter paper (16) and were performed with 1 ml of mid-log-phase cultures of each organism. Following overnight incubation at 37°C on the filters, organisms were suspended in L broth and plated onto OFPBL agar containing 50 ,ug of kanamycin per ml, to determine whether the conjugation was successful, or 50 ,ug of kanamycin and 100 ,ug of chloramphenicol per ml, to screen for chloramphenicol-resistant transconjugants.
Construction of a broad-host-range plasmid encoding CAT. The 1.0-kb Sau3A fragment from pUC18-CM which encodes CAT production was inserted into the BamHI site of pUC18, and this construct was used to transform E. coli HB101 (27) . Plasmid DNA was purified from an ampicillin-and chloramphenicol-resistant clone. This plasmid, pJLB1, was digested with HindIII, as was the broad-host-range plasmid pTJS75; the two plasmids were ligated and used to transform E. coli C2110. An ampicillin-, chloramphenicol-, and tetracyclineresistant colony was selected; and the 10.7-kb plasmid that it contained, pJLB2, was transferred into P. cepacia by triparental mating.
MICs. Determination of the MIC of chloramphenicol was performed by agar dilution with a Steers replicator (42) with an inoculum of 105 CFU.
Assay for CAT. Cell extracts were prepared by sonication as described previously (6) , and CAT activity was assayed by the spectrophotometric technique of Shaw and Brodsky (41) . One unit of CAT activity was defined as 1 ,umol of chloramphenicol-dependent 5,5'-dithiobis-2-nitrobenzoic acid reacted per min (with a millimolar extinction coefficient of 13.6 at 412 nm). The specific activity was calculated as milliunits per milligram of protein. Protein determination was done by the method of Lowry et al. (26) by using crystalline bovine serum albumin as a standard.
In vitro translation. Whole bacterial cells were made permeable with ether (6) and were used to examine the effect of chloramphenicol on the translation of endogenous mRNA. In some experiments, cells were preincubated with sub-MICs of chloramphenicol prior to extraction with ether. Extracted cells were incubated in buffer with an amino acid mixture containing [14C]valine (specific activity, 50 mCi/ mmol). Chloramphenicol was added to each reaction in concentrations ranging from 1 to 100 ,ug/ml; control reactions were run without chloramphenicol.
Chloramphenicol uptake. The cellular permeability of chloramphenicol was determined as described previously (7) in whole bacterial cells which contained a plasmid encoding CAT production. The decrease in drug concentration in culture supernatants was quantitated by high-pressure liquid chromatography over a 20-h incubation period.
Outer membrane proteins. Outer membrane proteins were isolated from P. cepacia by a modification of the Triton X-100 solubilization technique described by Stull et al. (43) . Cells were disrupted with a French pressure cell (Aminco) at 20,000 lb/in2 in the presence of 20% sucrose, 50 ,ug of DNase per ml, 50 ,ug of RNase per ml, and 200 ,ug of lysozyme per ml in 30 mM Tris hydrochloride (pH 8.0). The membrane pellet which resulted from ultracentrifugation at 48,000 x g was extracted with 2% Triton X-100 in 30 mM Tris hydrochloride (pH 8.0) at 20°C for 30 min. Following washing twice in distilled water, suspended membranes were analyzed by sodium dodecyl sulfate (SDS)-10% polyacrylamide gel electrophoresis by the method of Laemmli (25) . Proteins were visualized by staining them in 0.1% Coomassie brilliant blue (17) .
Lipopolysaccharide. Lipopolysaccharide (LPS) was isolated from P. cepacia by the method of Darveau and Hancock (11) . LPS extracts were analyzed by SDS-15% polyacrylamide gel electrophoresis in which 2 M urea was incorporated and were visualized by the silver staining technique of Tsai and Frasch (44) . RESULTS Cloning of the chloramphenicol resistance gene. A total of 325 kanamycin-resistant E. coli colonies with P. cepacia insert DNA were screened, but none of them were resistant to chloramphenicol. To rule out the possibility that the resistance gene was not expressed in E. coli, the clones were scraped from the surface of agar plates and conjugated with P. cepacia 249-2 by triparental mating. Multiple kanamycinand chloramphenicol-resistant colonies were identified, all of which appeared to contain the same 44.9-kb plasmid, pLIN1. After isolation and purification, pLIN1 was found to contain 23 kb of vector DNA (pVK102) and 21.9 kb of P. cepacia insert DNA.
VOL. 33, 1989 on September 28, 2017 by guest http://aac.asm.org/ Downloaded from MIC. The MICs of chloramphenicol, trimethoprim, and ciprofloxacin for strains K61-3 (the isolate from a patient with CF), 249-2 (the laboratory recipient strain), 249-2(pVK102) (the recipient plus vector), and 249-2(pLIN1) (the recipient with the vector plus insert DNA) are listed in Table  2 . The cloned fragment encoded resistance to trimethoprim and ciprofloxacin, in addition to resistance to chloramphenicol.
CAT activity. There was no detectable CAT production by strains 249-2, K61-3, or 249-2(pLIN1); the two strains into which pJLB2 was conjugated, 249-2(pJLB2) and 249-2(pLIN1, pJLB2), produced equivalent amounts of CAT (Table 2) . No CAT activity was detected in culture supernatants of 249-2(pJLB2) or 249-2(pLIN1, pJLB2).
In vitro translation. The results of in vitro translation experiments are shown in Fig. 1 . The activity of strain K61-3 was compared with that of a chloramphenicol-susceptible strain, PC104 (MIC, 5 ,ug/ml). Because no differences in ribosomal susceptibility were seen in these two col in the two strains. To rule out the possibility that an inducible ribosomal resistance was operating, K61-3 cells were preincubated with 20 j,g of chloramphenicol per ml prior to extraction with ether; again, no differences were seen between susceptible and resistant strains (Fig. 1) .
Chloramphenicol uptake. Chloramphenicol penetration into whole bacterial cells was compared in the isogenic strains 249-2 and 249-2(pLIN1) containing pJLB2, which codes for the production of CAT. CAT modified the chloramphenicol within the cell to maintain the concentration gradient across the membrane. The results of uptake experiments are shown in Fig. 2 . A marked difference in drug uptake was seen at all time points. At 1 h there was nearly a 10-fold difference between 249-2(pJLB2) and 249-2(pLIN1, pJLB2): 8.9 + 1.55 versus 81.64 ± 9.36 jig/ml, respectively, remaining in culture supernatants.
Outer membrane protein profiles. A Coomassie bluestained SDS-polyacrylamide gel comparing outer membrane protein profiles of strains 249-2, 249-2(pVK102), 249-2(pLIN1), and K61-3 is shown in Fig. 3 . There were no consistent differences identified between the chloramphenicol-susceptible or -resistant isogenic strains. However, on some gels (including the one in Fig. 3 ) an 18-kilodalton protein was visible in strain 249-2(pLIN1) that was not identified in the other isogenic strains. Strain K61-3 was included for comparison, although since it was not isogenic, differences in the outer membrane protein pattern were difficult to interpret. Its pattern did not show the 18-kilodalton protein.
LPS patterns. Figure 4 shows the pattern of LPS extracted from the isogenic chloramphenicol-susceptible and -resistant strains 249-2 and 249-2(pLIN1). Again, no significant differences in LPS patterns were detected.
DISCUSSION
Bacterial resistance to chloramphenicol may be caused by inactivation by CAT (40, 41) , ribosomal resistance (33), or impermeability (6, 7, 14, 29) . In P. aeruginosa, 50 to 85% of resistant strains produce CAT (29, 32) . In the remainder, resistance is caused by decreased outer membrane permeability (7, 24, 29) In this study we demonstrated that decreased permeability is a mechanism of chloramphenicol resistance in P. cepacia. We were unable to detect either production of CAT or ribosomal resistance to chloramphenicol in the high-levelresistant strain that we investigated. After cloning the resistance marker into a susceptible P. cepacia strain and conjugating a plasmid encoding CAT production into the same strain, we were able to demonstrate a 10-fold difference in chloramphenicol uptake between the susceptible and resistant strains. The MICs for the organisms also differed by 10-fold.
Despite the fact that we identified no structural alterations in outer membrane proteins (including porins) or LPS, the difference in chloramphenicol uptake between the susceptible and resistant strains was likely caused by outer membrane impermeability. In addition, several studies of antibiotic resistance in P. cepacia have suggested that decreased outer membrane permeability plays a key role. Chemical antibacterial agents such as quaternary ammonium compounds are effective against P. cepacia only at high concentrations. Resistance to these compounds is increased even further by the addition of the chelating agent EDTA (36) and by depletion of magnesium in the culture medium (10) . This is opposite from the effects of divalent cations on the outer membrane of other gram-negative bacteria including P. aeruginosa, E. coli, and Salmonella species (18) . In these organisms, the presence of a chelating agent increases permeability and thereby increases susceptibility to antimicrobial agents.
Recent data from Moore and Hancock (30) confirm that P. cepacia is resistant to the outer membrane-permeabilizing effects of EDTA. They reported that although LPS in intact P. cepacia cells lacks binding sites for polycations (such as the aminoglycosides, polymyxin, and a fluorescent polycation, dansylpolymyxin), purified LPS from the same strains had an affinity for dansylpolymyxin equal to that of P. aeruginosa. In addition, Parr et al. (34) measured the permeability coefficient of P. cepacia K61-3. The porin-mediated permeability of this strain to the P-lactam nitrocefin was low, comparable to that of P. aeruginosa. However, strain K61-3 was not compared with an antibiotic-susceptible strain of P. cepacia.
Although the unique organization of the outer membrane of P. cepacia makes it a likely site for a permeability barrier, decreased permeability across the inner membrane is also possible. Active transport of chloramphenicol across the cytoplasmic membrane has been demonstrated in Haemophilus influenzae (8) . Alterations in this cytoplasmic membrane pump could be a mechanism of chloramphenicol resistance in P. cepacia. However, the cloned DNA fragment codes for cross-resistance to trimethoprim and ciprofloxacin, in addition to chloramphenicol, suggesting that the permeability barrier is nonspecific and therefore not at the level of the cytoplasmic membrane.
We conclude that the mechanism of chloramphenicol resistance in isolate K61-3, which was obtained from a patient with CF, is decreased membrane permeability. Although no structural differences were detected between the isolated outer membrane proteins and the LPS of isogenic susceptible and resistant strains, the most likely resistance mechanism is structural or functional differences that are present in intact outer membranes. Conversely, a decrease in the inner membrane pumping of chloramphenicol could be VOL. 33, 1989 on September 28, 2017 by guest http://aac.asm.org/ Downloaded from responsible for the decrease in drug entry into the cell. Further studies, including the construction of membrane vesicles, are required to fully examine these possibilities.
